New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
Read more about Bharat Biotech to ramp up Covaxin production, make 200 mn doses a year on Business Standard. Product availability of additional doses to commence from Q4, 2021 at Chiron Behring Vaccines Ltd, located in Ankleshwar, Gujarat, Bharat Biotech says
I was unaware of govt efforts : Nitin Gadkari after suggestion to let more firms make Covid vaccines
Gadkari said he was unaware that the Centre had alreay started these efforts before he had given a suggestion yesterday. This is what Dr Manmohan Singh had suggested on April 18th. But is his Boss listening, asks Congress Jairam Ramesh
BusinessToday.In | May 19, 2021 | Updated 15:10 IST
Union minister Nitin Gadkari
After Union minister Nitin Gadkari sparked a controversy over the huge demand for vaccines against production in the country, he clarified today saying he was unaware of the fact that the Centre is already facilitating vaccine manufacturing by 12 different plants or companies.
भारत न्यूज़: वैक्सीन कैसे बनती है, यह दूसरों को बता भी दिया जाए तो किसी भी कंपनी को टीके बनाने का काम शुरू करने में 6 से 8 महीने का वक्त लग सकता है। टीके बनाने के लिए बायो सेफ्टी लेवल-3 वाली जगह तैयार करने और उसे मंजूरी मिलने में ही 3 से 6 महीने लग जाएंगे।
Centre provides Rs 220 cr grant, Covaxin s monthly production to cross 10 cr doses by Sep
Among the public sector companies, Mumbai-based Haffkine Biopharmaceutical Corporation Ltd has been provided a grant of Rs 65 crore for manufacturing Covaxin.
BusinessToday.In | May 15, 2021 | Updated 18:15 IST
Production of Covaxin is expected to reach more than 10 crore doses per month by September, 2021.
The Centre has provided financial assistance in the form of grant of Rs 220 crore to vaccine manufacturers to boost the production of Bharat Biotech s COVID-19 vaccine Covaxin, and its production is expected to reach more than 10 crore doses per month by September this year.
The Department of Biotechnology, which is implementing Mission COVID Suraksha announced as part of Atmanirbhar Bharat 3.0 to accelerate development and production of indigenous COVID-19 vaccines, has provided financial assistance to vaccine manufacturers, the Ministry of Science & Technology said in a statement.